| ACS | Acute coronary syndromes |
| CAD | Coronary artery disease |
| CCL5 | C-C motif ligand 5 |
| CCR1 | C-C chemokine receptor type 1 |
| COX1 | Cyclooxygenase-1 |
| CVD | Cardiovascular disease |
| CXCL1 | C-X-C motif chemokine ligand 1 |
| CXCL4 | C-X-C motif chemokine ligand 4 |
| ECM | Extracellular matrix |
| ECs | Endothelial cells |
| EVs | Extracellular vesicles |
| GCX | Glycocalyx |
| HMGB1 | High mobility group box protein 1 |
| IL | Interleukin |
| ICAM1 | Intercellular Adhesion Molecule 1 |
| MI | Myocardial infarction |
| MCP1 | Monocyte chemoattractant protein-1 |
| MAC | Membrane attack complexes |
| MMPs | Matrix metalloproteinases |
| NETs | Neutrophil-extracellular traps |
| NO | Nitric oxide |
| NPA | Neutrophil–platelet aggregates |
| ox-LDL | oxidized low-density lipoprotein |
| PAD | Peripheral artery disease |
| PDT | Photodynamic therapy |
| PF4 | Platelet factor 4 |
| PMC | Platelet–monocyte complexes |
| PMPs | Platelet microparticles |
| PDGF | Platelet-derived growth factor |
| PSGL1 | P-selectin glycoprotein ligand-1 |
| RANTES | Regulated upon activation normal T expressed and secreted |
| ROS | Reactive oxygen species |
| STAT3 | Signal Transducer and Activator of Transcription 3 |
| TNF-α | Tumor necrosis factor-alpha |
| TGF-β | transforming growth factor beta |
| UCNPs | Upconversion nanoparticles |
| VCAM1 | Vascular Cell Adhesion Molecule-1 |
| VEGF | Vascular endothelial growth factor |
| VSMCs | Vascular smooth muscle cells |
| vWF | von Willebrand factor |